BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16849562)

  • 1. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.
    Deglesne PA; Chevallier N; Letestu R; Baran-Marszak F; Beitar T; Salanoubat C; Sanhes L; Nataf J; Roger C; Varin-Blank N; Ajchenbaum-Cymbalista F
    Cancer Res; 2006 Jul; 66(14):7158-66. PubMed ID: 16849562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
    Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
    Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
    Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
    Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
    Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
    Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
    Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
    N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.
    Scupoli MT; Pizzolo G
    Expert Rev Hematol; 2012 Jun; 5(3):341-8. PubMed ID: 22780213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
    Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
    Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
    Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
    Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia.
    Chen YH; Peterson LC; Dittmann D; Evens A; Rosen S; Khoong A; Shankey TV; Forman M; Gupta R; Goolsby CL
    Am J Clin Pathol; 2007 Feb; 127(2):182-91. PubMed ID: 17210531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
    Efremov DG; Gobessi S; Longo PG
    Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Igawa T; Sato Y; Takata K; Fushimi S; Tamura M; Nakamura N; Maeda Y; Orita Y; Tanimoto M; Yoshino T
    Cancer Sci; 2011 Nov; 102(11):2103-7. PubMed ID: 21790895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.
    Longo PG; Laurenti L; Gobessi S; Petlickovski A; Pelosi M; Chiusolo P; Sica S; Leone G; Efremov DG
    Leukemia; 2007 Jan; 21(1):110-20. PubMed ID: 17024114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
    Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M
    Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.